Pandemic-Related Price-Gouging Would Be False, Misleading Advertising Under House, Senate Bills
Executive Summary
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
You may also be interested in...
Consumer Health Fraud Didn’t Start With COVID-19, Senators And Witnesses Say At Hearing
“Dietary supplements are among the most poorly regulated consumer products,” CSPI policy director tells Senate Manufacturing, Trade and Consumer Protection Subcommittee. Ranking member Blumenthal says scams won’t end soon. “We’re six months into this pandemic with no end in sight.”
Federal Official Would Monitor 'Price Gouging’ Under Latest US House Pandemic Relief Bill
Legislation also provides the US Biomedical Advanced Research and Development Authority with $3.5bn to advance research and development, manufacturing, production and the purchase of vaccines and therapeutics.
Covid-19 Scam Complaints Double In A Week, But FTC Enforcement Considers 'Good Faith' Factor
FTC pursuing bogus health and other products or services capitalizing on Covid-19 fear with scams skyrocketing. However, FTC says its enforcement will consider whether businesses are making good faith efforts to produce products in high demand.